
Response to Miller et al: resistant mutations in CML and Ph(+) ALL – role of ponatinib
Author(s) -
Nathalie Bardy-Bouxin,
Ewa Matczak,
Geeta Devgan,
Mabel Woloj,
Mark Shapiro
Publication year - 2015
Publication title -
biologics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.948
H-Index - 38
eISSN - 1177-5491
pISSN - 1177-5475
DOI - 10.2147/btt.s79507
Subject(s) - ponatinib , myeloid leukemia , miller , philadelphia chromosome , medicine , lymphoblastic leukemia , leukemia , genetics , biology , cancer research , dasatinib , chromosomal translocation , imatinib , ecology , gene